Connor, Clark & Lunn Investment Management (CC&L)
COGT icon

Connor, Clark & Lunn Investment Management (CC&L)’s Cogent Biosciences COGT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio COGT Stock Details COGT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.25M Buy
2024
Q1 		– Sell
2023
Q4 		$492K Sell
2023
Q3 		$2.2M Sell
2023
Q2 		$3.27M Buy
2023
Q1 		$2.97M Buy
2022
Q4 		$3.16M Buy
2022
Q3 		$3.88M Buy
2022
Q2 		$1.57M Buy